Latest Breaking News On - Preclinical studies - Page 5 : comparemela.com

Enzolytics, Inc : Enzolytics Announces Progress in the Development and Patenting of Feline Leukemia Monoclonal Antibodies

COLLEGE STATION, TX / ACCESSWIRE / April 4, 2023 / Enzolytics, Inc. (OTC PINK:ENZC) (https://enzolytics.com/).Enzolytics today announced progress on its ongoing program to produce Monoclonal Antibodies

United statesCharles cotropiaGaurav chandraEnzolytics inc viewWhile enzolytics incEnzolytics incBiogenysis incCompany contactCompany artificial intelligenceWhile the companyTexasam university institute for preclinicalMonoclonal antibodiesFeline leukemiaArtificial intelligenceEbola virusCat feline leukemia virus

Can-Fite BioPharma (CANF) Reports FY22, Provides Clinical Update

Can-Fite BioPharma (CANF) Reports FY22, Provides Clinical Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMotti farbsteinKiryat matalonPnina fishmanFite biopharmaClinical development highlightsSoroka medical centerExchange commissionFite biopharma ltdTrademark office granted canEuropean medicines agencyDrug administrationCompany annual report on formWall streetClinical development highlights includePsoriasis trial met primary endpoint

Can-Fite Reports 2022 Financial Results & Provides Clinical Update

PETACH TIKVA, Israel (BUSINESS WIRE) Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory

United statesPnina fishmanMotti farbsteinFite biopharmaKiryat matalonSoroka medical centerTrademark office granted canExchange commissionClinical development highlightsCompany annual report on formFite biopharma ltdEuropean medicines agencyDrug administrationCan fite biopharmaClinical development highlights includeTrial met primary endpoint

Outlook on the KRAS Inhibitors Global Market, Drug Price,

Dublin, Feb. 08, 2023 (GLOBE NEWSWIRE) The "Global KRAS Inhibitors Market, Drug Price, Sales, & Clinical Trials Insight 2029" report has been.

United statesUnited kingdomSouth koreaBridgebio pharmaAscentage pharmaLumakras sotorasibGenhouse bioAdagrasib krazatiEuregen biopharmaJiangsu hengrui medicine coJacobio pharmaceuticalsLeidos biomedical researchBoehringer ingelheimInhibitors clinical pipeline by companyYale cancer centreDrug price

Automation as a drug discovery accelerator

Accelerating parts of the drug discovery process by combining automation and analytical technologies is essential for the pharmaceutical industry. Read more here.

United statesDanielle ellisZyabich shutterstockTechnical programSpectroscopy society of pittsburghSociety for analytical chemists of pittsburghAutomation in pharmaceuticalsCongressional budget officeSponsored contentImage creditBudget officePharmaceutical industryComputer aided molecular designComputational approachesPreclinical studiesDrug discovery